ATE287707T1 - Injizierbare propofol-formulierungen - Google Patents

Injizierbare propofol-formulierungen

Info

Publication number
ATE287707T1
ATE287707T1 AT99936010T AT99936010T ATE287707T1 AT E287707 T1 ATE287707 T1 AT E287707T1 AT 99936010 T AT99936010 T AT 99936010T AT 99936010 T AT99936010 T AT 99936010T AT E287707 T1 ATE287707 T1 AT E287707T1
Authority
AT
Austria
Prior art keywords
formulations
propofol
injectable
methylpyrrolidone
useful
Prior art date
Application number
AT99936010T
Other languages
English (en)
Inventor
Gene Komer
Original Assignee
Veterinary Res Associates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veterinary Res Associates Inc filed Critical Veterinary Res Associates Inc
Application granted granted Critical
Publication of ATE287707T1 publication Critical patent/ATE287707T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99936010T 1998-07-31 1999-07-30 Injizierbare propofol-formulierungen ATE287707T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/127,082 US5962536A (en) 1998-07-31 1998-07-31 Injectable propofol formulations
PCT/US1999/017433 WO2000006142A1 (en) 1998-07-31 1999-07-30 Injectable propofol formulations

Publications (1)

Publication Number Publication Date
ATE287707T1 true ATE287707T1 (de) 2005-02-15

Family

ID=22428216

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936010T ATE287707T1 (de) 1998-07-31 1999-07-30 Injizierbare propofol-formulierungen

Country Status (10)

Country Link
US (1) US5962536A (de)
EP (1) EP1131062B1 (de)
JP (1) JP2002521434A (de)
AT (1) ATE287707T1 (de)
AU (1) AU755613B2 (de)
CA (1) CA2338684C (de)
DE (1) DE69923471T2 (de)
ES (1) ES2237132T3 (de)
NZ (1) NZ510469A (de)
WO (1) WO2000006142A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
US6150423A (en) * 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US7034013B2 (en) * 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
EP1430017A2 (de) 2001-09-26 2004-06-23 Theravance, Inc. Substituierter phenolverbindungen zur anästhesie und sedierung
WO2003087888A2 (en) * 2002-04-10 2003-10-23 Verification Technologies, Inc. Content replication deterrent method on optical discs
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
CA2494297C (en) * 2002-07-29 2011-10-18 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US20040171691A1 (en) * 2002-10-29 2004-09-02 Transform Pharmaceuticals, Inc. Propofol with cysteine
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
AU2003260943A1 (en) * 2003-06-10 2005-01-04 Shashikant Prabhudas Kurani Improved novel, clear, painless preparation of propofol
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US20050163718A1 (en) * 2004-01-23 2005-07-28 Shugart Jack I. Injectable euthanasia compositions that include a taste aversive agent
NZ571818A (en) 2006-03-08 2011-10-28 Nihon Nohyaku Co Ltd External pharmaceutical composition comprising luliconazole and an alpha-hydroxycarboxylic acid such as lactic acid, glycolic acid or malic acid.
AU2006339842B2 (en) * 2006-03-08 2012-06-07 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
BRPI0604377A (pt) * 2006-10-27 2008-06-24 Cristalia Prod Quimicos Farm microemulsão óleo/água de propofol estável e pronta-para-uso
CN101808638B (zh) * 2007-09-05 2012-07-25 宝丽制药股份有限公司 抗真菌组合物
PL2191828T3 (pl) * 2007-09-05 2017-02-28 Pola Pharma Inc. Przeciwgrzybicza kompozycja farmaceutyczna
US20100204293A1 (en) * 2007-09-05 2010-08-12 Pola Pharma Inc. Pharmaceutical composition
JP2011500798A (ja) * 2007-10-26 2011-01-06 アストラゼネカ・アクチエボラーグ ｍＧｌｕＲ５のモジュレーターとしてのアミノ１，２，４−トリアゾール誘導体
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN107049936B (zh) * 2017-04-17 2018-11-23 南京健友生化制药股份有限公司 含防腐剂的苯磺顺阿曲库铵注射液的放大生产方法
US20230086729A1 (en) * 2021-08-27 2023-03-23 Slayback Pharma Llc Stable pharmaceutical compositions of succinylcholine chloride

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1053736B (de) * 1956-03-02 1959-03-26 Konink Nl Gist & Spiritusfabri Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5496537A (en) * 1995-03-23 1996-03-05 Henry; Richard A. Propofol hydrofluorocarbon propellant formulations
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof

Also Published As

Publication number Publication date
NZ510469A (en) 2002-12-20
DE69923471D1 (de) 2005-03-03
CA2338684C (en) 2006-02-14
CA2338684A1 (en) 2000-02-10
AU755613B2 (en) 2002-12-19
WO2000006142A1 (en) 2000-02-10
ES2237132T3 (es) 2005-07-16
EP1131062B1 (de) 2005-01-26
JP2002521434A (ja) 2002-07-16
EP1131062A1 (de) 2001-09-12
US5962536A (en) 1999-10-05
AU5136899A (en) 2000-02-21
DE69923471T2 (de) 2006-03-30
EP1131062A4 (de) 2002-07-03

Similar Documents

Publication Publication Date Title
DE69923471D1 (de) Injizierbare propofol-formulierungen
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
EE9900156A (et) Kondenseerunud 1-bensüül-3-(asendatud heteroarüül)pürasooli derivaadid
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
EA199900598A1 (ru) Производные 1-арил- и пиридилпиразола с пестицидными свойствами
DE59906975D1 (de) Wässrige reaktive spachtelmassen (i)
BR9709551A (pt) Composicões de limpeza ácidas contendo goma de xantano
ES2195970T3 (es) L-ribavirina y usos de la misma.
ATE251108T1 (de) Compositionen auf basis von resveratrolderivaten
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
BR9806296B1 (pt) compostos de ácido sulfìnico, mistura, composição e uso dos mesmos.
BR9916894A (pt) ácidos sulfohidroxâmicos e sulfohidroxamatos eseu uso como inibidores de mek
BR9801652A (pt) Resorcinil-triazinas
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
SE9602818D0 (sv) Colored composition
ATE428403T1 (de) Stabilisierte azithromycin-zusammensetzungen
ATE352354T1 (de) Kosmetische und dermatologische lichtschutzformulierungen mit einem gehalt an benzotriazolderivaten und alkylnapthalaten
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
DE60116359D1 (de) Kahalalid f formulierung
DE60320232D1 (de) Haarfärbezusammensetzungen auf basis von diaminopyrazolverbindungen
BR9903585A (pt) Composição de borracha que contém material anti-reversão e pneu com com componente da mesma
BR0116152B1 (pt) aditivo adequado para uso como emulsificador e solubilizador, uso de um aditivo, e, composição.
EA199800534A1 (ru) ПРИМЕНЕНИЕ 2-ЭТИЛГЕКСИЛ-α-ЦИАНО-β, β-ДИФЕНИЛАКРИАТА ДЛЯ УЛУЧШЕНИЯ СТАБИЛЬНОСТИ КОСМЕТИЧЕСКИХ КОМПОЗИЦИЙ, СОДЕРЖАЩИХ П-МЕТИЛБЕНЗИЛИДЕНКАМФОРУВ СОЧЕТАНИИ С ДИБЕНЗОИЛМЕТАНОВЫМ ПРОИЗВОДНЫМ
BG100248A (bg) Инхибитори на скваленсинтетаза
TR200001724T2 (tr) 5-HT1F Agonistleri

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties